Skip to content
Trial Eligibility
Menu

Better Options for Chronic Cancer Pain

NCT06574009

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This proposal is relevant to the 240,000 cancer survivors who continue to use opioids long after they have successfully completed treatment for cancer at the VHA, placing them at risk of opioid addiction and overdose, and other opioid-related problems. Yet, there are no programs at the VHA to help them find alternatives to opioids, nor evidence to inform the choice of interventions.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Chronic Pain
  • Cancer Survivor
  • Opioid Dependence

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 99 years
Sex
All
Healthy volunteers
Accepted
Sponsor
VA Office of Research and Development
Last updated on ClinicalTrials.gov
May 11, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Michigan · 1

  • VA Ann Arbor Healthcare System, Ann Arbor, MI · Ann Arbor, MI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.